Could We Detect Breast Cancer with a Fingerprint? | Simona Francese | TED

Quick Overview

The speaker proposes that breast cancer could potentially be detected non-invasively using chemical analysis of fingerprint secretions, which showed an 86% accuracy in classifying samples from 15 patients into benign, early cancer, or metastatic categories using MALDI Mass Spectrometry and machine learning.

Key Points: One in eight women will develop breast cancer, and one in 43 diagnosed women will die, with projected annual cases reaching 70,000 by 2040. The speaker highlights that traditional screening methods like mammograms face issues such as NHS backlogs, reduced resources, and patient concerns about invasiveness and pain. The research uses Matrix Assisted Laser Desorption Ionisation Mass Spectrometry Imaging (MALDI MSI) to analyze molecules present in fingertip sweat. A proof-of-concept study involving 15 patients (benign, early cancer, metastatic) used three fingertip smears per sample, resulting in 135 spectra analyzed. Machine learning prediction on this chemical data achieved 97.8% accuracy in classifying samples into their respective groups. The proposed non-invasive test promises NHS savings, increased accessibility, and reduced strain on resources by bypassing mammograms and radiologists. The ultimate goal is to validate this method for non-invasive breast cancer detection, potentially saving lives by increasing compliance.

Context: Simona Francese presents a TED talk focusing on the urgent need for better, non-invasive breast cancer screening methods, contrasting the grim statistics of breast cancer incidence and mortality with the known barriers to current screening like mammography. She introduces a novel approach involving chemical analysis of compounds found in fingertip sweat, leveraging forensic techniques to potentially identify cancer biomarkers, thereby offering a less painful and more accessible screening option.

Detailed Analysis

Simona Francese opens by stating alarming statistics: 1 in 8 women develop breast cancer, 1 in 43 diagnosed women die, and cases are predicted to hit 70,000 annually by 2040. She details current screening issues, including NHS backlogs, resource shortages (radiologists/equipment), and patient fears regarding the invasiveness and pain of mammograms, leading to low uptake (sometimes as low as 50% nationally against a 70% target). Francese then pivots to a 'serendipitous discovery' linking forensic fingerprint analysis to cancer detection. She explains that the compounds excreted through sweat pores in fingerprints contain molecular patterns that differ between healthy and cancerous individuals. Using MALDI MSI, they analyzed the molecular profiles of sweat from 15 patients (benign, early cancer, metastatic). The workflow involved preparing 45 samples, running MALDI MS analysis, and feeding the data into a machine learning algorithm. This process achieved a 97.8% accuracy in classifying samples. The speaker suggests this non-invasive, painless, radiation-free test could bypass current screening bottlenecks, save NHS costs, reduce stress, and, crucially, increase compliance, thereby saving more lives.